Warner Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Warner Group's REGN Position: Q2 2026 in Review
Warner Group increased its Regeneron Pharmaceuticals (REGN) stake by 101% in Q2 2026, buying an estimated $549K and bringing the position to 1,606 shares worth $1M. The position accounts for 0.25% of the portfolio, ranked #47.
Warner Group first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Warner Group held 1,606 shares of Regeneron Pharmaceuticals worth $1M as of Q2 2026.
- Warner Group bought 807 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $549K.
- Regeneron Pharmaceuticals made up 0.25% of Warner Group's portfolio in Q2 2026, its #47 holding.
- Warner Group first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Warner Group's 13F filing for Q2 2026, filed 27 Jul 2026.